| Description | PAD (aa 462-477) antibody (V3S-0324-FY88) was developed to specifically target amino acids 462 to 477 of PAD2, showcasing cross-reactivity with PAD2 and PAD4, and exhibiting a high affinity for binding to both PAD2 and PAD4. PAD (aa 629-645) antibody (V3S-0324-FY89) was developed specifically to bind to region 629-645 of PAD4. Our research findings indicate that this antibody exhibits cross-reactivity with PAD2, PAD3 and PAD4, and is capable of binding to both PAD2, PAD3 and PAD4 with high affinity. |
| Clonality | Monoclonal |
| Host Species | Mouse |
| Target Species | Human, Mouse |
| Epitope | Amino acids 462-477 |
| Isotype | Mouse IgG |
| Expression Species | HEK293F or CHO |
| Conjugation | None |
| Purity | >95%, determined by SDS-PAGE and SEC-HPLC |
| Endotoxin | <1 EU/mg |
| Purification | Protein G affinity purified |
| Sterility | 0.2 μM filtered |
| Formulation | PBS, pH 7.4 |
| Preservation | No preservatives |
| Stabilizer | No stabilizers |
| Storage | Store at 4°C within a week. For longer storage, aliquot and store at -20°C. |
| Application | ELISA |
| Application Notes | ELISA: 10 μg/mL |
| ELISA | Enzyme-Linked Immunosorbent Assay Protocol |
| WB | Western Blot Protocol |
| FC | Flow Cytometry Protocol |
| Target | PAD |
| Alternative Name | Peptidylarginine deiminase; PAD |
| Related pathway | Autophagy |
| Research Area | Autophagy |
| Related Disease | Autoimmune disease |
